Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis.

PubWeight™: 3.45‹?› | Rank: Top 1%

🔗 View Article (PMC 3367096)

Published in J Allergy Clin Immunol on April 26, 2012

Authors

Carol J Henderson1, J Pablo Abonia, Eileen C King, Philip E Putnam, Margaret H Collins, James P Franciosi, Marc E Rothenberg

Author Affiliations

1: Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229-3039, USA.

Articles citing this

Food allergy testing in eosinophilic esophagitis: what the gastroenterologist needs to know. Clin Gastroenterol Hepatol (2013) 2.17

Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2012) 1.90

Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet (2014) 1.87

High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders. J Allergy Clin Immunol (2013) 1.35

Dietary elimination therapy is an effective option for adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol (2014) 1.34

A role for food allergy testing in eosinophilic esophagitis. J Allergy Clin Immunol (2012) 1.07

Therapeutic concepts in adult and paediatric eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol (2012) 0.94

Eosinophilic esophagitis. Gastroenterol Clin North Am (2012) 0.91

Eosinophils in Gastrointestinal Disorders: Eosinophilic Gastrointestinal Diseases, Celiac Disease, Inflammatory Bowel Diseases, and Parasitic Infections. Immunol Allergy Clin North Am (2015) 0.87

Increased Risk of Esophageal Eosinophilia and Eosinophilic Esophagitis in Patients With Active Celiac Disease on Biopsy. Clin Gastroenterol Hepatol (2015) 0.85

A pilot study of omalizumab in eosinophilic esophagitis. PLoS One (2015) 0.85

Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding. Semin Immunopathol (2012) 0.84

The role of allergy evaluation in children with eosinophilic esophagitis. J Gastroenterol (2013) 0.83

Management of Eosinophilic Esophagitis During Pregnancy. Dig Dis Sci (2016) 0.81

Elemental diet decreases inflammation and improves symptoms in adult eosinophilic oesophagitis patients. Aliment Pharmacol Ther (2017) 0.79

Reply: To PMID 22541246. J Allergy Clin Immunol (2012) 0.78

High rate of galactose-alpha-1,3-galactose sensitization in both eosinophilic esophagitis and patients undergoing upper endoscopy. Dis Esophagus (2015) 0.78

Elimination diets in the management of eosinophilic esophagitis. J Asthma Allergy (2014) 0.78

Diagnostic and therapeutic strategies for eosinophilic esophagitis. Clin Pract (Lond) (2014) 0.78

Eosinophilic esophagitis in children from Western saudi arabia: relative frequency, clinical, pathological, endoscopic, and immunological study. Gastroenterol Res Pract (2012) 0.78

The Immunologic Mechanisms of Eosinophilic Esophagitis. Curr Allergy Asthma Rep (2016) 0.77

IgE-associated food allergy alters the presentation of paediatric eosinophilic esophagitis. Clin Exp Allergy (2016) 0.77

Food and aeroallergens in eosinophilic esophagitis: role of the allergist in patient management. Curr Opin Gastroenterol (2014) 0.77

The Role of Environmental Exposures in the Etiology of Eosinophilic Esophagitis: A Systematic Review. Mayo Clin Proc (2015) 0.76

Longitudinal Perspective on Managing Refractory Eosinophilic Esophagitis. J Allergy Clin Immunol Pract (2015) 0.76

Food allergy and the gut. Nat Rev Gastroenterol Hepatol (2016) 0.75

Dietary therapy in pediatric eosinophilic esophagitis. Gastroenterology (2012) 0.75

Management of proton pump inhibitor responsive-esophageal eosinophilia and eosinophilic esophagitis: controversies in treatment approaches. Expert Rev Gastroenterol Hepatol (2015) 0.75

Therapeutic strategies in eosinophilic esophagitis: Induction, maintenance and refractory disease. Best Pract Res Clin Gastroenterol (2015) 0.75

Cost Utility Analysis of Topical Steroids Compared to Dietary Elimination for Treatment of Eosinophilic Esophagitis. Clin Gastroenterol Hepatol (2016) 0.75

Eosinophilic esophagitis: an emerging disease in childhood - review of diagnostic and management strategies. Front Pediatr (2014) 0.75

Unmet therapeutic needs in eosinophilic esophagitis. Dig Dis (2014) 0.75

Aeroallergens in Eosinophilic Esophagitis: Significant Triggers or Noise in the System? J Pediatr Gastroenterol Nutr (2016) 0.75

Combination Steroid and Test-based Food Elimination for Eosinophilic Esophagitis: A Retrospective Analysis. J Pediatr Gastroenterol Nutr (2017) 0.75

Food-specific IgG4 is associated with eosinophilic esophagitis. J Allergy Clin Immunol (2016) 0.75

Topical glucocorticoid vs. diet therapy in eosinophilic esophagitis: the need for better treatment options. Expert Rev Clin Immunol (2016) 0.75

Eosinophil progenitor levels are increased in patients with active pediatric eosinophilic esophagitis. J Allergy Clin Immunol (2016) 0.75

The TGFβ1 Promoter SNP C-509T and Food Sensitization Promote Esophageal Remodeling in Pediatric Eosinophilic Esophagitis. PLoS One (2015) 0.75

Do We Know What Causes Eosinophilic Esophagitis? A Mechanistic Update. Curr Gastroenterol Rep (2015) 0.75

Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults. Ann Allergy Asthma Immunol (2016) 0.75

Hematopoietic prostaglandin D synthase: Linking pathogenic effector CD4(+) TH2 cells to proeosinophilic inflammation in patients with gastrointestinal allergic disorders. J Allergy Clin Immunol (2016) 0.75

Should wheat, barley, rye, and/or gluten be avoided in a 6-food elimination diet? J Allergy Clin Immunol (2015) 0.75

Managing eosinophilic esophagitis: challenges and solutions. Clin Exp Gastroenterol (2016) 0.75

From genetics to treatment of eosinophilic esophagitis. Curr Opin Allergy Clin Immunol (2015) 0.75

Eosinophilic Esophagitis in Children. Curr Allergy Asthma Rep (2017) 0.75

Management of refractory eosinophilic oesophagitis. Nat Rev Gastroenterol Hepatol (2017) 0.75

Current Diagnostic and Treatment Strategies for Eosinophilic Esophagitis. Gastroenterol Hepatol (N Y) (2017) 0.75

Six-Food Elimination Diet and Topical Steroids are Effective for Eosinophilic Esophagitis: A Meta-Regression. Dig Dis Sci (2017) 0.75

Articles cited by this

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology (2007) 9.05

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48

Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J Allergy Clin Immunol (2001) 4.31

Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology (1995) 4.24

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology (2006) 3.68

Relationship between food-specific IgE concentrations and the risk of positive food challenges in children and adolescents. J Allergy Clin Immunol (1997) 3.57

Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann Allergy Asthma Immunol (2005) 3.53

Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol (2005) 3.34

An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest (2001) 3.32

Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol (2003) 3.05

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98

Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J Pediatr Gastroenterol Nutr (1998) 2.87

Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol (2006) 2.78

Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology (2010) 2.76

Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology (2002) 2.52

The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J Allergy Clin Immunol (2002) 2.43

Local B cells and IgE production in the oesophageal mucosa in eosinophilic oesophagitis. Gut (2010) 2.31

Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol (2008) 2.19

Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol (2007) 2.18

Biology and treatment of eosinophilic esophagitis. Gastroenterology (2009) 2.18

A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol (2011) 1.82

Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology (2005) 1.78

Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol (2007) 1.73

Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol (2010) 1.63

Interpreting skin prick tests in the evaluation of food allergy in children. Pediatr Allergy Immunol (1998) 1.62

Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J Allergy Clin Immunol (2007) 1.61

Critical role for adaptive T cell immunity in experimental eosinophilic esophagitis in mice. J Leukoc Biol (2006) 1.56

Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol (2007) 1.28

Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol (2011) 1.20

Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr (2011) 1.17

Quality of life in paediatric eosinophilic oesophagitis: what is important to patients? Child Care Health Dev (2011) 0.98

Acquired coenzyme Q10 deficiency in children with recurrent food intolerance and allergies. Mitochondrion (2010) 0.92

Proposal for a standardized interpretation of the atopy patch test in children with atopic dermatitis and suspected food allergy. Pediatr Allergy Immunol (2006) 0.87

Treatment adherence in pediatric eosinophilic gastrointestinal disorders. J Pediatr Psychol (2011) 0.86

Eosinophilic oesophagitis: epidemiology, clinical aspects, and association to allergy. J Pediatr Gastroenterol Nutr (2007) 0.85

Medical and nutrition management of eosinophilic esophagitis in children. Nutr Clin Pract (2010) 0.84

Food allergy and eosinophilic esophagitis: learning what to avoid. Cleve Clin J Med (2010) 0.84

Emerging management concepts for eosinophilic esophagitis in children. J Gastroenterol Hepatol (2011) 0.82

Articles by these authors

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48

Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology (2007) 9.05

Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest (2006) 5.48

Eosinophilic esophagitis. N Engl J Med (2004) 4.43

Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08

Eosinophils: biological properties and role in health and disease. Clin Exp Allergy (2008) 3.92

Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy. J Allergy Clin Immunol (2009) 3.74

A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology (2006) 3.68

Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol (2006) 3.51

IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol (2007) 3.24

Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol (2006) 3.04

MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol (2009) 2.89

Refining the definition of hypereosinophilic syndrome. J Allergy Clin Immunol (2010) 2.74

Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team. Clin Trials (2009) 2.49

Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet (2010) 2.47

Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology (2003) 2.40

CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature (2009) 2.39

Foxa2 regulates alveolarization and goblet cell hyperplasia. Development (2004) 2.35

Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol (2003) 2.31

IL-9- and mast cell-mediated intestinal permeability predisposes to oral antigen hypersensitivity. J Exp Med (2008) 2.19

Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol (2007) 2.18

Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest (2003) 2.17

Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease. Pediatrics (2012) 2.16

Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin Gastroenterol Hepatol (2008) 2.12

Hypoxia-induced acute lung injury in murine models of sickle cell disease. Am J Physiol Lung Cell Mol Physiol (2003) 2.08

IL-5 promotes eosinophil trafficking to the esophagus. J Immunol (2002) 2.06

Chemokines in asthma: cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol (2003) 2.06

Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels. J Allergy Clin Immunol (2008) 2.04

Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med (2002) 2.04

Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J Allergy Clin Immunol (2010) 2.00

MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol (2011) 2.00

Intestinal epithelial cell secretion of RELM-beta protects against gastrointestinal worm infection. J Exp Med (2009) 1.97

Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.92

Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol (2004) 1.87

Importance of cytokines in murine allergic airway disease and human asthma. J Immunol (2010) 1.86

Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer (2003) 1.86

Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol (2010) 1.85

Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. Am J Physiol Lung Cell Mol Physiol (2007) 1.85

Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol (2006) 1.84

A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol (2011) 1.82

Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol (2011) 1.82

Molecular mechanisms of anaphylaxis: lessons from studies with murine models. J Allergy Clin Immunol (2005) 1.80

MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol (2012) 1.79

Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J Allergy Clin Immunol (2006) 1.79

Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology (2005) 1.78

Prevalence and outcome of allergic colitis in healthy infants with rectal bleeding: a prospective cohort study. J Pediatr Gastroenterol Nutr (2005) 1.78

Biology of the eosinophil. Adv Immunol (2009) 1.74

Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.74

The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol (2005) 1.73

Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia. Gastroenterology (2007) 1.71

An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology (2011) 1.67